ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 102 filers reported holding ARATANA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $519,000 | +119.9% | 100,644 | +53.5% | 0.00% | – |
| Q1 2019 | $236,000 | -70.5% | 65,574 | -49.7% | 0.00% | -100.0% |
| Q4 2018 | $799,000 | +71.8% | 130,395 | +63.6% | 0.00% | – |
| Q3 2018 | $465,000 | +72.9% | 79,692 | +26.1% | 0.00% | – |
| Q2 2018 | $269,000 | +17.0% | 63,204 | +21.0% | 0.00% | – |
| Q1 2018 | $230,000 | +14.4% | 52,237 | +36.4% | 0.00% | – |
| Q4 2017 | $201,000 | +5.8% | 38,296 | +23.6% | 0.00% | – |
| Q3 2017 | $190,000 | -12.8% | 30,985 | +2.8% | 0.00% | – |
| Q2 2017 | $218,000 | +45.3% | 30,127 | +6.6% | 0.00% | – |
| Q1 2017 | $150,000 | -26.8% | 28,252 | -0.9% | 0.00% | – |
| Q4 2016 | $205,000 | -49.4% | 28,509 | -34.2% | 0.00% | -100.0% |
| Q3 2016 | $405,000 | +128.8% | 43,307 | +54.9% | 0.00% | – |
| Q2 2016 | $177,000 | +34.1% | 27,958 | +16.6% | 0.00% | – |
| Q1 2016 | $132,000 | -62.6% | 23,969 | -62.1% | 0.00% | -100.0% |
| Q4 2015 | $353,000 | – | 63,173 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 5,184,942 | $31,784,000 | 4.70% |
| AWM Investment Company, Inc. | 1,562,517 | $9,578,000 | 1.67% |
| Opaleye Management Inc. | 420,000 | $2,574,000 | 0.91% |
| MPM ASSET MANAGEMENT LLC | 250,000 | $1,533,000 | 0.75% |
| GENERAL AMERICAN INVESTORS CO INC | 867,600 | $5,318,000 | 0.50% |
| Grandeur Peak Global Advisors, LLC | 538,363 | $3,300,000 | 0.50% |
| Redmond Asset Management, LLC | 55,941 | $343,000 | 0.16% |
| WOODSTOCK CORP | 88,303 | $541,000 | 0.10% |
| CADENCE CAPITAL MANAGEMENT LLC | 173,808 | $1,065,000 | 0.07% |
| Sheaff Brock Investment Advisors, LLC | 71,000 | $435,000 | 0.06% |